Perrigo Company plc (NYSE:PRGO – Get Free Report) declared a quarterly dividend on Friday, November 1st,RTT News reports. Investors of record on Friday, November 29th will be given a dividend of 0.276 per share on Tuesday, December 17th. This represents a $1.10 annualized dividend and a yield of 3.83%. The ex-dividend date is Friday, November 29th.
Perrigo has raised its dividend by an average of 6.7% per year over the last three years and has increased its dividend every year for the last 22 years. Perrigo has a dividend payout ratio of 35.8% meaning its dividend is sufficiently covered by earnings. Research analysts expect Perrigo to earn $3.08 per share next year, which means the company should continue to be able to cover its $1.10 annual dividend with an expected future payout ratio of 35.7%.
Perrigo Stock Performance
NYSE:PRGO opened at $28.84 on Thursday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo has a fifty-two week low of $23.89 and a fifty-two week high of $34.60. The business has a 50 day moving average price of $25.99 and a 200-day moving average price of $27.05. The firm has a market cap of $3.93 billion, a PE ratio of -24.65 and a beta of 0.48.
Insider Buying and Selling
In other Perrigo news, Director Katherine C. Doyle sold 8,954 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $27.30, for a total value of $244,444.20. Following the sale, the director now owns 6,009 shares in the company, valued at approximately $164,045.70. This represents a 59.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.70% of the stock is owned by insiders.
Analyst Ratings Changes
PRGO has been the topic of a number of recent analyst reports. StockNews.com upgraded Perrigo from a “hold” rating to a “buy” rating in a research report on Thursday, November 7th. Canaccord Genuity Group reissued a “buy” rating and set a $42.00 price objective on shares of Perrigo in a research report on Monday, September 30th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $30.00 target price (down previously from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Perrigo has an average rating of “Moderate Buy” and a consensus price target of $37.00.
View Our Latest Research Report on Perrigo
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Stories
- Five stocks we like better than Perrigo
- What is the S&P/TSX Index?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.